TrianglePUBLICATIONS · 8879381
Cisplatin, doxorubicin and cyclophosphamide in advanced salivary gland carcinoma. A phase II trial of 22 patients.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Ann Oncol
- Publication date
- 1996 Aug
- First author
- Licitra L
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Licitra L
- type
- Author
- name
- Cavina R
- type
- Author
- name
- Grandi C
- type
- Author
- name
- Palma SD
- type
- Author
- name
- Guzzo M
- type
- Author
- name
- Demicheli R
- type
- Author
- name
- Molinari R
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Licitra L
- type
- Author
- name
- Cavina R
- type
- Author
- name
- Grandi C
- type
- Author
- name
- Palma SD
- type
- Author
- name
- Guzzo M
- type
- Author
- name
- Demicheli R
- type
- Author
- name
- Molinari R
- type
- Author
- bibliography ids
- nci-bib-92309831aec407613c3e423c
- book metadata
- content sha256
- 2fd64aedaa9af3cf070fa71dbf82e1e4688ea4112e0162621aa098efb070686f
- document type
- citation
- dois
- 10.1093/oxfordjournals.annonc.a010684
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:8879381
- immutable id
- pubmed:8879381@2fd64aedaa9af3cf070fa71dbf82e1e4688ea4112e0162621aa098efb070686f
- journal
- abbreviation
- Ann Oncol
- issn electronic
- Source null
- issn print
- 0923-7534
- issue
- 6
- name
- Annals of oncology : official journal of the European Society for Medical Oncology
- nlm unique id
- 9007735
- pages
- 640-2
- volume
- 7
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 8879381
- provenance
- batch id
- 2752791f8cc3526b9192
- provider
- NCBI PubMed ESummary
- record sha256
- 7b8b36239e967ffcb29bf3fee89b69bdd8f9db0acbbab67835934553683294ab
- response sha256
- 8db42d042a938e99e944b9e6af6caf1dd877725c05485e70efac12add1ee08e9
- retrieved at
- 2026-09-09T23:45:25.088603+00:00
- publication date
- display
- 1996 Aug
- precision
- month
- year
- 1996
- publication types
- Clinical Trial
- Clinical Trial, Phase II
- Journal Article
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- source url
- https://pubmed.ncbi.nlm.nih.gov/8879381/
- title
- Cisplatin, doxorubicin and cyclophosphamide in advanced salivary gland carcinoma. A phase II trial of 22 patients.
Preserved source evidence · Not medical advice